NextCure, Inc. financial data

Symbol
NXTC on Nasdaq
Location
9000 Virginia Manor Road, Suite 200, Beltsville, MD
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 1, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.27K % -40.9%
Debt-to-equity 14.2 % +70.1%
Return On Equity -57.6 % -31.8%
Return On Assets -50.5 % -25%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 28M shares +0.49%
Common Stock, Shares, Outstanding 28M shares +0.49%
Entity Public Float 49.2M USD -57.4%
Common Stock, Value, Issued 28K USD 0%
Weighted Average Number of Shares Outstanding, Basic 28M shares +0.52%
Weighted Average Number of Shares Outstanding, Diluted 28M shares +0.52%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 46.7M USD -9.31%
General and Administrative Expense 17M USD -22%
Operating Income (Loss) -66.2M USD +9.6%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -61.3M USD +12.7%
Earnings Per Share, Basic -2.19 USD/shares +13.1%
Earnings Per Share, Diluted -2.19 USD/shares +13.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 20.8M USD -5.32%
Assets, Current 90.5M USD -33.1%
Property, Plant and Equipment, Net 6.7M USD -36.3%
Operating Lease, Right-of-Use Asset 3.56M USD -24.4%
Other Assets, Noncurrent 1.87M USD -34.4%
Assets 103M USD -33.1%
Accounts Payable, Current 5.08M USD +80.4%
Employee-related Liabilities, Current 992K USD -39.5%
Accrued Liabilities, Current 3.94M USD -6.83%
Liabilities, Current 10.8M USD +38.5%
Operating Lease, Liability, Noncurrent 5.59M USD -11.1%
Other Liabilities, Noncurrent 725K USD -14%
Liabilities 17.1M USD +14.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax -86K USD +90.7%
Retained Earnings (Accumulated Deficit) -357M USD -20.7%
Stockholders' Equity Attributable to Parent 85.4M USD -38.3%
Liabilities and Equity 103M USD -33.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -12.6M USD +14.7%
Net Cash Provided by (Used in) Financing Activities 1K USD
Net Cash Provided by (Used in) Investing Activities 17.9M USD -1.33%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 28M shares +0.49%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 5.28M USD +57.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 20.8M USD -5.32%
Interest Paid, Excluding Capitalized Interest, Operating Activities 19K USD -9.52%
Deferred Tax Assets, Valuation Allowance 99M USD +24.1%
Deferred Tax Assets, Gross 100M USD +23.5%
Operating Lease, Liability 6.29M USD -8.51%
Payments to Acquire Property, Plant, and Equipment 37K USD -85.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -60.4M USD +12.1%
Lessee, Operating Lease, Liability, to be Paid 7.83M USD -12.3%
Property, Plant and Equipment, Gross 29.3M USD +2.58%
Operating Lease, Liability, Current 656K USD +26.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.36M USD +20.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.21M USD +126%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.54M USD -24.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.4M USD +15%
Deferred Tax Assets, Operating Loss Carryforwards 56.4M USD +13.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.44M USD +6.13%
Operating Lease, Payments 1.03M USD +12.6%
Additional Paid in Capital 442M USD +1.71%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 1.38M USD -10.3%
Share-based Payment Arrangement, Expense 7.27M USD -17.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%